News

May 2010 issue of IJTLD now available online

IJTLD Cover
IJTLD

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union). The IJTLD is the reference for clinical research and epidemiological studies on tuberculosis. It is also the only peer-reviewed journal dedicated to lung health worldwide, including articles on TB-HIV and non tuberculosis related respiratory diseases such as asthma, acute respiratory infection, COPD, child lung health and the hazards of tobacco and pollution – all topics that reflect the wide scope of the activities of The Union and its members.

Volume 13, Number 5, May 2010 is now available online.

Table of Contents:

(Content Key: Free Content – Free New Content – New)

Free Content Content loaded within last 14 days Why hasn’t human genetics told us more about asthma? [Editorial. 2010: The Year of the Lung. Series editor: John F. Murray]
pp. 521-523(3)
Author: Annesi-Maesano, Isabella

Free Content Content loaded within last 14 days Good news: asthma medicines for all [Editorial. 2010: The Year of the Lung. Series editor: John F. Murray]
pp. 524-524(1)
Author: Billo, Nils E.

Content loaded within last 14 days Preventing the next generation of extensively drug-resistant tuberculosis [Unresolved issues]
pp. 525-527(3)
Authors: Ben Amor, Y.; Day, M.S.; Schluger, N.W.

Free Content Content loaded within last 14 days Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities [State of the art series. Drug-resistant tuberculosis. Edited by C-Y. Chiang. Number 5 in the series]
pp. 528-537(10)
Authors: Lienhardt, C.; Davies, G.

Content loaded within last 14 days Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering
pp. 538-544(7)
Authors: Kato-Maeda, M.; Kim, E.Y.; Flores, L.; Jarlsberg, L.G.; Osmond, D.; Hopewell, P.C.

Content loaded within last 14 days Interferon-gamma release assay clarifies the effect of bacille Calmette-Guérin vaccination in Greek army recruits
pp. 545-550(6)
Authors: Katsenos, S.; Nikolopoulou, M.; Konstantinidis, A.K.; Gartzonika, C.; Gogali, A.; Margelis, I.; Tatsioni, A.; Mavridis, A.; Constantopoulos, S.H.; Daskalopoulos, G.

Content loaded within last 14 days Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment
pp. 551-559(9)
Authors: Trajman, A.; Long, R.; Zylberberg, D.; Dion, M.J.; Al-Otaibi, B.; Menzies, D.

Content loaded within last 14 days Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients
pp. 560-570(11)
Authors: Hesseling, A.C.; Walzl, G.; Enarson, D.A.; Carroll, N.M.; Duncan, K.; Lukey, P.T.; Lombard, C.; Donald, P.R.; Lawrence, K.A.; Gie, R.P.; van Helden, P.D.; Beyers, N.

Content loaded within last 14 days Added value of bleach sedimentation microscopy for diagnosis of tuberculosis: a cost-effectiveness study
pp. 571-577(7)
Authors: Bonnet, M.; Tajahmady, A.; Hepple, P.; Ramsay, A.; Githui, W.; Gagdnidze, L.; Guérin, P.J.; Varaine, F.

Content loaded within last 14 days Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of extra-pulmonary tuberculosis
pp. 578-584(7)
Authors: Berzosa, M.; Tsukayama, D.T.; Davies, S.F.; Debol, S.M.; Cen, Y-Y.; Li, R.; Mallery, S.

Content loaded within last 14 days Neighbourhood risk factors for tuberculosis in Hong Kong
pp. 585-592(8)
Authors: Pang, P.T-T.; Leung, C.C.; Lee, S.S.

Content loaded within last 14 days Duplicates and misclassification of tuberculosis notification records in Brazil, 2001-2007
pp. 593-599(7)
Authors: Bierrenbach, A.L.; Pinto de Oliveira, G.; Codenotti, S.; Gomes, A.B.F.; Stevens, A.P.

Content loaded within last 14 days Incidence of tuberculosis in people living with the human immunodeficiency virus in Saudi Arabia
pp. 600-603(4)
Authors: Omair, M.A.; Al-Ghamdi, A.A.; Alrajhi, A.A.

Content loaded within last 14 days Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia
pp. 604-610(7)
Authors: Vassall, A.; Seme, A.; Compernolle, P.; Meheus, F.

Content loaded within last 14 days Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya
pp. 611-615(5)
Authors: Huerga, H.; Spillane, H.; Guerrero, W.; Odongo, A.; Varaine, F.

Content loaded within last 14 days Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment
pp. 616-621(6)
Authors: Chien, J-Y.; Huang, R-M.; Wang, J-Y.; Ruan, S-Y.; Chien, Y-J.; Yu, C-J.; Yang, P-C.

Content loaded within last 14 days NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis
pp. 622-626(5)
Authors: Lee, S-W.; Chung, L.S-C.; Huang, H-H.; Chuang, T-Y.; Liou, Y-H.; Wu, L.S-H.

Content loaded within last 14 days MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan
pp. 627-634(8)
Authors: Wang, C-H.; Lin, H-C.; Lin, S-M.; Huang, C-D.; Liu, C-Y.; Huang, K-H.; Hsieh, L-L.; Chung, K.F.; Kuo, H-P.

Content loaded within last 14 days Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan
pp. 635-641(7)
Authors: Shu, C-C.; Lee, L-N.; Wang, J-T.; Chien, Y-J.; Wang, J-Y.; Yu, C-J.; Taiwan Anti-Mycobacteria Investigation TAMI Group,

Content loaded within last 14 days A pilot trial of non-invasive home ventilation after acidotic respiratory failure in chronic obstructive pulmonary disease
pp. 642-649(8)
Authors: Cheung, A.P.S.; Chan, V.L.; Liong, J.T.; Lam, J.Y.M.; Leung, W-S.; Lin, A.; Chu, C-M.

Content loaded within last 14 days Recording isoniazid preventive therapy delivery to children: operational challenges [Short communication]
pp. 650-653(4)
Authors: Van Wyk, S.S.; Hamade, H.; Hesseling, A.C.; Beyers, N.; Enarson, D.A.; Mandalakas, A.M.

Content loaded within last 14 days Isolation of non-tuberculous mycobacteria from the sputum of patients with active tuberculosis [Short communication]
pp. 654-656(3)
Authors: Kendall, B.A.; Varley, C.D.; Hedberg, K.; Cassidy, P.M.; Winthrop, K.L.

Content loaded within last 14 days Tuberculous meningitis in a patient with acute human immunodeficiency virus infection [Correspondence]
pp. 657-657(1)
Authors: Gabrielli, Eugenia; Rusconi, Stefano; Olivetti, Micol; Galli, Massimo; Riva, Agostino; Gervasoni, Cristina

Content loaded within last 14 days Amikacin-induced hypomagnesaemic tetany complicating multidrug-resistant tuberculosis treatment [Correspondence]
pp. 657-658(2)
Authors: Dauby, Nicolas; Payen, Marie-Christine

Content loaded within last 14 days Selenium and tuberculosis [Correspondence]
pp. 658-659(2)
Author: Wiwanitkit, Viroj

Content loaded within last 14 days In reply to `Selenium and tuberculosis’ [Correspondence]
pp. 659-659(1)
Author: Eick, Frode

Content loaded within last 14 days Analyses of sputum specimens for the diagnosis of pulmonary tuberculosis in a rural hospital in Ethiopia [Correspondence]
pp. 659-660(2)
Authors: Ramos, José M.; Vélez, Monica; Reyes, Francisco

Content loaded within last 14 days Drug resistance in Kerala [Correspondence]
pp. 660-661(2)
Authors: Chauhan, L.S.; Wares, Fraser; Sahu, Suvanand; Dewan, Puneet; Chadha, Sarabit; Thirumala, Ajay; Ramachandran, Ranjani

Content loaded within last 14 days In reply to `Drug resistance in Kerala’ [Correspondence]
pp. 661-662(2)
Authors: Joseph, B.V.; Soman, S.; Radhakrishnan, I.; Madhavilatha, G.K.; Paul, L.K.; Mundayoor, S.; Kumar, R.A.

Content loaded within last 14 days Fostering incomprehensibility with acronyms and abbreviations [Correspondence]
pp. 662-662(1)
Author: Rieder, H.L.

Content loaded within last 14 days In reply to `Fostering incomprehensibility with acronyms and abbreviations’ [Correspondence]
pp. 662-662(1)
Author: Pierard, Clare

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...